NCT01409382

Brief Summary

tPA has a pivotal role in placentation, mediationg activation of growth factors, such as vascular endothelial growth factor and brain-derived neurotrophic factor, degradation of extracellular matrix and basement membrane (directly or through activation of matrix metalloproteinases) and formation of hemidesmosomes. A high-carbohydrate intake combined with lack of physical activity provides a strong stimulus for maternal insulin production. In this scenario, either β-cells are dysfunctional and diabetes supervenes, or excessive amounts of insulin are produced, providing pathological stimulation of PAI-1 synthesis. Given that PAI-1 is a major tPA inhibitor, PAI-1 excess may affect placentation, increasing the risk of first trimester losses, preterm deliveries and intrauterine growth restriction. Our hypothesis was that prematurity was not the cause of neonatal hypoglycemia, but a parallel occurrence of a strong stimulus for maternal, fetal and neonatal production of insulin.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
480

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2011

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

May 27, 2011

Completed
2 months until next milestone

First Posted

Study publicly available on registry

August 4, 2011

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2013

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2015

Completed
4 months until next milestone

Results Posted

Study results publicly available

January 21, 2016

Completed
Last Updated

September 29, 2016

Status Verified

August 1, 2016

Enrollment Period

2.1 years

First QC Date

May 27, 2011

Results QC Date

April 26, 2013

Last Update Submit

August 19, 2016

Conditions

Keywords

neonatal hypoglycemiapregnancyphysical activitysedentary lifestylehigh-glycemic index diettake-home babyrecurrent miscarriagespreterm delivery

Outcome Measures

Primary Outcomes (1)

  • Neonatal Hypoglycemia

    Any glucose level equal or below 40mg/dL at 1, 2 or 4 h after birth, obtained by heelstick.

    1, 2 and 4 h after birth.

Secondary Outcomes (1)

  • Refractory Hypoglycemia

    One hour after feeding or after intravenous dextrose

Other Outcomes (1)

  • Pregnancy and Neonatal Outcomes

    Three years

Study Arms (2)

Lifestyle counseling

ACTIVE COMPARATOR

Daily brisk walking plus a carbohydrate-restricted diet

Behavioral: Daily brisk walking plus a carbohydrate-restricted diet

Standard follow-up

NO INTERVENTION

Prenatal care will proceed according to the routine.

Interventions

Daily brisk walking at moderate speed (4 km/h) for at least 40 minutes per day, 7 days a week. Patients will be recommended to avoid high-glycemic index meals (such as snacks, candies, fiber-free juices and sugar-sweetened beverages), and to eat at least two daily servings of meat, poultry, fish (e.g. 2 g/kg) or other protein-rich food, starting when they decided to get pregnant and continuing until delivery. Recommendations will be emphasised at every appointment. Antidepressants will not be discontinued in both groups, but patients on paroxetine and sertraline, will be switched to fluoxetine.

Lifestyle counseling

Eligibility Criteria

AgeUp to 40 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Federal dos Servidores do Estado

Rio de Janeiro, Rio de Janeiro, 20221-903, Brazil

Location

Related Publications (1)

  • Hoirisch-Clapauch S, Porto MAS. Early neonatal hypoglycemia prediction according to maternal parameters. Thrombosis Research 131(1): S96, 2013.

    RESULT

Related Links

MeSH Terms

Conditions

HyperinsulinismAbortion, SpontaneousSedentary BehaviorHypoglycemiaMotor ActivityAbortion, HabitualPremature Birth

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesBehaviorObstetric Labor, PrematureObstetric Labor Complications

Results Point of Contact

Title
Dr. Silvia Hoirisch-Clapauch
Organization
Hospital Federal dos Servidores do Estado

Study Officials

  • Maria A Sayeg-Porto, MD, PhD

    Hospital dos Servidores do Estado, RJ; Universidade Federal do Rio de Janeiro

    PRINCIPAL INVESTIGATOR
  • Paulo R Benchimol-Barbosa, MD, DSc

    Universidade Gama Filho; COPPE/UFRJ

    PRINCIPAL INVESTIGATOR
  • Silvia Hoirisch-Clapauch, MD

    Hospital dos Servidores do Estado, RJ

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

May 27, 2011

First Posted

August 4, 2011

Study Start

March 1, 2011

Primary Completion

April 1, 2013

Study Completion

October 1, 2015

Last Updated

September 29, 2016

Results First Posted

January 21, 2016

Record last verified: 2016-08

Data Sharing

IPD Sharing
Will share

Locations